Skip to main content

Published locations for ADA: Empagliflozin and liraglutide reduce type 2 CV death

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ADA: Empagliflozin and liraglutide reduce type 2 CV death

User login

  • Reset your password
  • /content/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /clinicianreviews/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /familypracticenews/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /internalmedicinenews/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv
  • /clinicalendocrinologynews/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv
  • /clinical-guidelines-hub/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv
  • /ecardiologynews/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /cardiology/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /endocrinology/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /internalmedicine/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /familymedicine/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv-death
  • /type-2-diabetes-icymi/article/126523/diabetes/ada-empagliflozin-and-liraglutide-reduce-type-2-cv